Karyopharm Therapeutics, Inc. (KPTIQ)
0.0174
-0.02
(-56.50%)
USD |
OTCM |
Nov 10, 16:00
0.0163
0.00 (0.00%)
After-Hours: 20:00
Karyopharm Therapeutics Debt to Equity Ratio : -0.7759 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.7759 |
| March 31, 2026 | -0.8691 |
| December 31, 2025 | -0.7975 |
| September 30, 2025 | -0.7295 |
| June 30, 2025 | -0.7978 |
| March 31, 2025 | -0.9068 |
| December 31, 2024 | -1.046 |
| September 30, 2024 | -1.217 |
| June 30, 2024 | -1.480 |
| March 31, 2024 | -1.044 |
| December 31, 2023 | -1.300 |
| September 30, 2023 | -1.769 |
| June 30, 2023 | -2.500 |
| March 31, 2023 | -3.953 |
| December 31, 2022 | -10.75 |
| September 30, 2022 | -1.280 |
| June 30, 2022 | -2.690 |
| March 31, 2022 | -3.770 |
| December 31, 2021 | -2.266 |
| September 30, 2021 | -2.488 |
| June 30, 2021 | -3.773 |
| March 31, 2021 | -6.421 |
| December 31, 2020 | 2.594 |
| September 30, 2020 | 2.424 |
| June 30, 2020 | 1.552 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.7597 |
| December 31, 2019 | 2.505 |
| September 30, 2019 | 2.058 |
| June 30, 2019 | 1.476 |
| March 31, 2019 | 0.9911 |
| December 31, 2018 | 0.5605 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Heron Therapeutics, Inc. | 26.80 |
| Tonix Pharmaceuticals Holding Corp. | 0.0063 |
| Minerva Neurosciences, Inc. | -0.7356 |
| Corbus Pharmaceuticals Holdings, Inc. | 0.0461 |
| Ocugen, Inc. | -5.009 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 111.32M |
| Total Liabilities (Quarterly) | 441.48M |
| Shareholders Equity (Quarterly) | -330.17M |
| Current Ratio | 0.7925 |
| Net Debt Paydown Yield | -6.27% |